Has Marion Douglass, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,140 in general payments to Marion Douglass, MD across 24 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Marion Douglass, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Marion Douglass, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Marion Douglass, MD

Psychiatry · Tucson, AZNPI 1720054299

Payments from drug & device makers

$1,140in general payments, 2019–2025

Across 24 payments — averaging $47.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$290
Gilead$228
E.r. Squibb & Sons, L.L.C.$209
Bioxcel Therapeutics, Inc.$125
Sunovion Pharmaceuticals Inc.$121
AbbVie$110
plus $57 from 2 others

What the payments were for

Food & beverage$1,140100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	6	$290
Gilead	2	$228
E.r. Squibb & Sons, L.L.C.	5	$209
Bioxcel Therapeutics, Inc.	1	$125
Sunovion Pharmaceuticals Inc.	1	$121
AbbVie	5	$110
Johnson & Johnson	2	$30
Indivior Inc.	2	$28

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,140 in reported general payments places this provider in the 75th percentile of 573 psychiatry providers in Arizona.

See all psychiatry providers in Arizona →

Medicare billing

Part B allowed, 2024

$12,459

Medicare patients

Services billed

196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxyzine Pamoate	15	$113
Trazodone Hcl	18	$91
Lorazepam	14	$34

Paid to pharmacies, not to this prescriber.

Other psychiatry in Tucson

Steven BuppTucson$451K
Shahzad AliTucson$213K
Brandon YatesTucson$118K
Marlene FreemanTucson$110K
Francisco MorenoTucson$40K
Jennifer TreuschTucson$29K
Samantha FrembgenTucson$9K
Peter KowalskiTucson$8K
Stephen StreitfeldTucson$6K
Richard BarnesTucson$5K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →